HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Botulinum toxin injection to the lateral rectus for the treatment of intractable diplopia].

Abstract
The aim of the study is to evaluate the use of botuline A (BTXA) as a form of treatment for squinting patients with onerous diplopia. Two patients with exotropia and one patient with esotropia had injections of BTX A to the lateral rectus muscles of the affected side. The number of injections ranged from 1 to 2. Two patients went on to have surgery. All patients in our study found that BTX A improved their symptoms of diplopia. We conclude that BTX A has an important role in the treatment of squinting patients with burdensome diplopia.
AuthorsAnna Broniarczyk-Loba, Iwona Laudańska-Olszewska, Olimpia Nowakowska
JournalKlinika oczna (Klin Oczna) Vol. 107 Issue 10-12 Pg. 690-3 ( 2005) ISSN: 0023-2157 [Print] Poland
Vernacular TitleZastosowanie iniekcji toksyny botulinowej do mieśnia prostego bocznego w celu zniesienia uciazliwego dwojenia.
PMID16619822 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Neuromuscular Agents
  • Botulinum Toxins, Type A
Topics
  • Adolescent
  • Adult
  • Botulinum Toxins, Type A (administration & dosage)
  • Diplopia (drug therapy)
  • Esotropia (drug therapy)
  • Exotropia (drug therapy)
  • Female
  • Humans
  • Male
  • Neuromuscular Agents (administration & dosage)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: